Angiotensin II directly increases transforming growth factor β1 and osteopontin and indirectly affects collagen mRNA expression in the human heart

Cardiovascular Research

Volumn 46, Issue 3, 2000, Pages 463-475

  Kupfahl, Claudio ^a   Pink, Daniel ^a   Friedrich, Katharina ^a   Zurbrügg, Heinz R ^b   Neuss, Michael ^a   Warnecke, Christina ^a   Fielitz, Jens ^a   Graf, Kristof ^a   Fleck, Eckart ^a   Regitz Zagrosek, Vera ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Angiotensin; Connective tissue; Fibrosis; Growth factors; Myocarditis

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; COLLAGEN; COLLAGEN TYPE 1; FIBRONECTIN; MESSENGER RNA; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; GENE EXPRESSION; HEART MUSCLE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

AGED; ANALYSIS OF VARIANCE; ANGIOTENSIN II; CELLS, CULTURED; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROBLASTS; FIBRONECTINS; GENE EXPRESSION; GROWTH SUBSTANCES; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; OSTEOPONTIN; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIALOGLYCOPROTEINS; STIMULATION, CHEMICAL; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034070354     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00037-7     Document Type: Article

References (50)

1. Weber K.T., Sun Y., Tyagi S.C., Cleutjens J.P. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol. 26:1994;279-292.
2. Villarreal F.J., Kim N.N., Ungab G.D., Printz M.P., Dillmann W.H. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation. 88:1993;2849-2861.
3. McEwan P., Gray G., Sherry L., Webb D., Kenyon C. Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. Circulation. 98:1998;2765-2773.
4. Crabos M., Roth M., Hahn A.W., Erne P. Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression. J Clin Invest. 93:1994;2372-2378.
5. Zhou G., Kandala J.C., Tyagi S.C., Katwa L.C., Weber K.T. Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem. 154:1996;171-178.
6. Weber K.T., Sun Y., Katwa L.C. Myofibroblasts and local angiotensin II in rat cardiac tissue repair. Int J Biochem Cell Biol. 29:1997;31-42.
7. Lee A.A., Dillmann W.H., McCulloch A.D., Villarreal F.J. Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol. 27:1995;2347-2357.
8. Campbell S.E., Katwa L.C. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol. 29:1997;1947-1958.
9. Ju H., Dixon I.M. Effect of angiotensin II on myocardial collagen gene expression. Mol Cell Biochem. 163-164:1996;231-237.
10. Siegert A., Ritz E., Orth S., Wagner J. Differential regulation of transforming growth factor receptors by angiotensin II and transforming growth factor-beta1 in vascular smooth muscle. J Mol Med. 77:1999;437-445.
11. Rossi P., Karsenty G., Roberts A.B., Roche N.S., Sporn M.B., de Crombrugghe B. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell. 52:1988;405-414.
12. Chung K.Y., Agarwal A., Uitto J., Mauviel A. An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J Biol Chem. 271:1996;3272-3278.
13. Sun Y., Zhang J.Q., Zhang J., Ramires F.J. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart. J Mol Cell Cardiol. 30:1998;1559-1569.
14. Gray M.O., Long C.S., Kalinyak J.E., Li H.T., Karliner J.S. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res. 40:1998;352-363.
15. Border W.A., Noble N.A. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 331:1994;1286-1292.
16. Ashizawa N., Graf K., Do Y.S., Nunohiro T., Giachelli C.M., Meehan W.P., Tuan T.L., Hsueh W.A. Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. J Clin Invest. 98:1996;2218-2227.
17. Singh K., Sirokman G., Communal C., Robinson K.G., Conrad C.H., Brooks W.W., Bing O.H., Colucci W.S. Myocardial osteopontin expression coincides with the development of heart failure. Hypertension. 33:1999;663-670.
18. Graf K., Do Y.S., Ashizawa N., Meehan W.P., Giachelli C.M., Marboe C.C., Fleck E., Hsueh W.A. Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation. 96:1997;3063-3071.
19. Gallagher A.M., Bahnson T.D., Yu H., Kim N.N., Printz M.P. Species variability in angiotensin receptor expression by cultured cardiac fibroblasts and the infarcted heart. Am J Physiol. 274:1998;H801-809.
20. Agocha A., Sigel A.V., Eghbali-Webb M. Characterization of adult human heart fibroblasts in culture: a comparative study of growth, proliferation and collagen production in human and rabbit cardiac fibroblasts and their response to transforming growth factor-beta1. Cell Tissue Res. 288:1997;87-93.
21. Neuss M., Regitz-Zagrosek V., Hildebrandt A., Fleck E. Human cardiac fibroblasts express an angiotensin receptor with unusual binding characteristics which is coupled to cellular proliferation. Biochem Biophys Res Commun. 204:1994;1334-1339.
22. Hafizi S., Wharton J., Morgan K. Expression of functional angiotensin-converting enzyme and AT1 receptors in cultured human cardiac fibroblasts. Circulation. 98:1998;2553-2559.
23. Wharton J., Morgan K., Rutherford R.A., Catravas J.D., Chester A., Whitehead B.F., De Leval M.R., Yacoub M.H., Polak J.M. Differential distribution of angiotensin AT2 receptors in the normal and failing human heart. J Pharmacol Exp Ther. 284:(1):1998;323-336.
24. Tsutsumi Y., Matsubara H., Ohkubo N., Mori Y., Nozawa Y., Murasawa S., Kijima K., Maruyama K., Masaki H., Moriguchi Y., Shibasaki Y., Kamihata H., Inada M., Iwasaka T. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res. 83:1998;1035-1046.
25. Ohkubo N., Matsubara H., Nozawa Y., Mori Y., Murasawa S., Kijima K., Maruyama K., Masaki H., Tsutumi Y., Shibazaki Y., Iwasaka T., Inada M. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation. 96:1997;3954-3962.
26. Neuss M., Regitz-Zagrosek V., Hildebrandt A., Fleck E. Isolation and characterisation of human cardiac fibroblasts from explanted adult hearts. Cell Tissue Res. 286:1996;145-153.
27. Bauer P., Regitz-Zagrosek V., Hofmeister J., Lokies J., Rolfs A., Hildebrandt A.G., Hetzer R., Fleck E. Reduced atrial angiotensin receptor type 1 mRNA content in end-stage heart failure - validation of a novel quantitative PCR-ELISA technique. J Mol Med. 74:1996;447-454.
28. Regitz-Zagrosek V., Fielitz J., Hummel M., Hildebrandt A., Hetzer R., Fleck E. Decreased expression of ventricular angiotensin receptor type 1 mRNA after human heart transplantation. J Mol Med. 74:1996;777-782.
29. Regitz-Zagrosek V., Fielitz J., Dreysse R., Hildebrandt A.G., Fleck E. Angiotensin receptor type 1 mRNA in human right ventricular endomyocardial biopsies - Downregulation in heart failure. Cardiovasc Res. 35:1997;99-105.
30. Regitz-Zagrosek V., Friedel N., Heymann A., Bauer P., Neuß M., Rolfs A., Steffen C., Hildebrandt A., Hetzer R., Fleck E. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation. 91:1995;1461-1471.
31. Regitz V., Hertrampf R., Rappolder M., Fleck E. Myocardial cAMP and norepinephrine content in relation to phosphodiesterase-inhibitor effects in human heart failure. Eur Heart J. 13:(Suppl.I):1992;1445.
32. Regitz V., Fleck E. Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol. 69:1992;1574-1580.
33. Atkinson D.E., Walton G.M. Adenosine triphosphate conservation in metabolic regulation. Rat liver citrate cleavage enzyme. J Biol Chem. 242:1967;3239-3241.
34. Fisher S.A., Absher M. Norepinephrine and ANG II stimulate secretion of TGF-beta by neonatal rat cardiac fibroblasts in vitro. Am J Physiol. 268:1995;C910-917.
35. Sharma H.S., van H.H., Goedbloed M.A., Verdouw P.D., Lamers J.M. Angiotensin II induced expression of transcription factors precedes increase in transforming growth factor-beta 1 mRNA in neonatal cardiac fibroblasts. Biochem Biophys Res Commun. 205:1994;105-112.
36. Fine A., Goldstein R.H. The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem. 262:1987;3897-3902.
37. Ohta K., Kim S., Hamaguchi A., Yukimura T., Miura K., Takaori K., Iwao H. Role of angiotensin II in extracellular matrix and transforming growth factor-beta 1 expression in hypertensive rats. Eur J Pharmacol. 269:1994;115-119.
38. Nunohiro T., Ashizawa N., Graf K., Do Y.S., Hsueh W.A., Yano K. Angiotensin II promotes remodelling-related events in cardiac fibroblasts. Heart Vessels. (Suppl 12):1997;201-204.
39. deBlois D., Lombardi D.M., Su E.J., Clowes A.W., Schwartz S.M., Giachelli C.M. Angiotensin II induction of osteopontin expression and DNA replication in rat arteries. Hypertension. 28:1996;1055-1063.
40. Butler W. The nature and significance of osteopontin. Connective Tissue Res. 23:1989;123-136.
41. Chapman D., Weber K.T., Eghbali M. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. Circ Res. 67:1990;787-794.
42. Pathak M., Young D., Sen S. Angiotensin II stimulated collagen production influenced by fibroblast-myocyte crosstalk. Circulation. 98:1998;I-624. Abstract.
43. Sun Y., Ramires F.J., Zhou G., Ganjam V.K., Weber K.T. Fibrous tissue and angiotensin II. J Mol Cell Cardiol. 29:1997;2001-2012.
44. Holzmeister J., Graf K., Warnecke C., Fleck E., Regitz-Zagrosek V. Protein kinase C-dependent regulation of the human AT1 promoter in vascular smooth muscle cells. Am J Physiol. 273:1997;H655-664.
45. Regitz-Zagrosek V., Neuß M., Warnecke C., Holzmeister J., Fleck E. Subtype 2 and atypical angiotensin receptors in the human heart. Basic Res Cardiol. 91:1996;73-77.
46. Iwami K., Ashizawa N., Do Y.S., Graf K., Hsueh W.A. Comparison of ANG II with other growth factors on Egr-1 and matrix gene expression in cardiac fibroblasts. Am J Physiol. 270:1996;H2100-H2107.
47. Lassegue B., Alexander R.W., Nickenig G., Clark M., Murphy T.J., Griendling K.K. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol Pharmacol. 48:1995;601-609.
48. Dudley D.T., Summerfelt R.M. Regulated expression of angiotensin II (AT2) binding sites in R3T3 cells. Peptides. 44:1993;199-206.
49. Iwai T., Takeda N., Tuchiya M., Arino T., Tanamura A., Nagano M. Effects of regression of cardiac hypertrophy on myocardial contractility and ventricular myosin isoenzymes. Mol Cell Biochem. 118:1992;99-103.
50. Hunter J.J., Chien K.R. Mechanisms of disease: Signaling pathways for cardiac hypertrophy and failure. N Engl J Med. 341:1999;1276-1283.